moxifloxacin hydrochloride

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Breast CancerChronic Obstructive Pulmonary DiseaseCataractNeutropenia

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

1

moxifloxacin hydrochloride

Italfarmaco

Approved

12

Tecentriq

Roche

Preclinical

363

Trodelvy

Gilead

Preclinical

374

Halaven

Eisai

Preclinical

385

Tykerb

GSK

Preclinical

806

Adriamycin

GGynecologic Oncology Group

Preclinical

877

Avastin

BBio-Thera Solutions

Preclinical

1538

Nolvadex

SSan Diego Pacific Oncology & Hematology Associates

Preclinical

789

Prolia

Amgen

Preclinical

1410

Gemzar

GGynecologic Oncology Group

Preclinical

22Show 40 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Cardiac Repolarization3 trials

A Study to Evaluate the Effect of Mipomersen on Cardiac Repolarization Conducted in Healthy Subjects

Completed·KKastle Therapeutics, LLC·Phase 1·NCT01090661·60 enrolled

Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

Completed·HHaisco-USA Pharmaceuticals, Inc.·Phase 1·NCT06795204·48 enrolled

Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects

Unknown status·BBeijing InnoCare Pharma Tech Co., Ltd.·Phase 1·NCT05660720·48 enrolled

Cataract2 trials

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

Completed·BBp Consulting, Inc·Phase 4·NCT00758199·49 enrolled

PRO-232 in Patients Subjected to Cataract Surgery

Recruiting·LLaboratorios Sophia S.A de C.V.·Phase 3·NCT07305987·134 enrolled

Concentration1 trial

Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects

Completed·BBausch & Lomb Incorporated·Phase 1·NCT00824070·105 enrolled

Phase 11 trial

Phase 1, QT/QTC Interval Study in Healthy Subjects

Completed·Vertex Pharmaceuticals·Phase 1·NCT01910415·200 enrolled

Chronic Obstructive Pulmonary Disease1 trial

A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Completed·Daiichi Sankyo·Phase 4·NCT05400369·140 enrolled

6 more indications

Neutropenia1 trial

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Terminated·EEuropean Organisation for Research and Treatment of Cancer - EORTC·N/A·NCT00062231·351 enrolled

Bacterial Infections1 trial

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Terminated·OOHSU Knight Cancer Institute·Phase 3·NCT00324324·240 enrolled

Single Dose1 trial

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 1·NCT07116915·160 enrolled

Breast Cancer1 trial

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Completed·SSun Yat-sen University·Phase 2·NCT03405168·35 enrolled

TED1 trial

Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval

Completed·Italfarmaco·Phase 1·NCT04821063·31 enrolled

Unspecified2 trials

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

Unknown status·AAngion Biomedica Corp·Phase 1·NCT04898907·48 enrolled

A Single-Center, Randomized, Partially Double-Blind, Placebo- and Active-Controlled, Four-period Crossover, Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

Completed·SShanghai Ark Biopharmaceutical Co., Ltd.·Phase 1·NCT06591845·34 enrolled

Details

Drug Info

Related News